Skip to main content

Table 2 Discontinuation rates at 6 weeks [15] and 1 year [48]

From: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study

 

6-week discontinuation rate (%)

Responder 1-year discontinuation rate (%)

Paliperidone ER

15.0 (assumed equal to risperidone and olanzapine)

26.7 (average of risperidone and olanzapine)

Risperidone

15.0

31.7

Olanzapine

15.0

25.4

Quetiapine

18.0

40.0

Ziprasidone

20.0

40.0 (assumed equal to quetiapine)

Aripiprazole

20.0 (assumed equal to ziprasidone)

40.0 (assumed equal to quetiapine)